Zobrazeno 1 - 10 of 41 pro vyhledávání: '"Derek L Connolly"'
1
Akademický článek
Treatment gaps in the implementation of LDL cholesterol control among high- and very high-risk patients in Europe between 2020 and 2021: the multinational observational SANTORINI studyResearch in context
Autor: Kausik K. Ray, Inaam Haq, Aikaterini Bilitou, Marius C. Manu, Annie Burden, Carlos Aguiar, Marcello Arca, Derek L. Connolly, Mats Eriksson, Jean Ferrières, Ulrich Laufs, Jose M. Mostaza, David Nanchen, Ernst Rietzschel, Timo Strandberg, Hermann Toplak, Frank L.J. Visseren, Alberico L. Catapano
Publikováno v: The Lancet Regional Health. Europe, Vol 29, Iss , Pp 100624- (2023)
Summary: Background: European data pre-2019 suggest statin monotherapy is the most common approach to lipid management for preventing cardiovascular (CV) events, resulting in only one-fifth of high- and very high-risk patients achieving the 2019 ESC/
Externí odkaz: https://doaj.org/article/32912a0f3308464fa848f83c48aeb9b3
Zobrazit plný text záznamu
2
Akademický článek
Evaluation of contemporary treatment of high- and very high-risk patients for the prevention of cardiovascular events in Europe – Methodology and rationale for the multinational observational SANTORINI study
Autor: Kausik K. Ray, Inaam Haq, Aikaterini Bilitou, Carlos Aguiar, Marcello Arca, Derek L. Connolly, Mats Eriksson, Jean Ferrières, Per Hildebrandt, Ulrich Laufs, Jose M. Mostaza, David Nanchen, Ernst Rietzschel, Timo Strandberg, Hermann Toplak, Frank L.J. Visseren, Alberico L. Catapano
Publikováno v: Atherosclerosis Plus, Vol 43, Iss , Pp 24-30 (2021)
Background and aims: Clinical practice before 2019 suggests a substantial proportion of high and very high CV risk patients taking lipid-lowering therapy (LLT) would not achieve the new LDL-C goals recommended in the 2019 ESC/EAS guidelines (
Externí odkaz: https://doaj.org/article/dbab45f4fb3240539a4e517d5daa6696
Zobrazit plný text záznamu
3
Akademický článek
Interactions Between Atrial Fibrillation and Natriuretic Peptide in Predicting Heart Failure Hospitalization or Cardiovascular Death
Autor: Paul F. Brady, Winnie Chua, Frantisek Nehaj, Derek L. Connolly, Alya Khashaba, Yanish J. V. Purmah, Muhammad J. Ul‐Qamar, Mark R. Thomas, Chetan Varma, Renate B. Schnabel, Tanja Zeller, Larissa Fabritz, Paulus F. Kirchhof
Publikováno v: Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 11, Iss 4 (2022)
Background Natriuretic peptides are routinely quantified to diagnose heart failure (HF). Their concentrations are also elevated in atrial fibrillation (AF). To clarify their value in predicting future cardiovascular events, we measured natriuretic pe
Externí odkaz: https://doaj.org/article/7e0ccd6ead5d413fade4e4dcc358f9c6
Zobrazit plný text záznamu
4
Evaluation of contemporary treatment of high- and very high-risk patients for the prevention of cardiovascular events in Europe – Methodology and rationale for the multinational observational SANTORINI study
Autor: Derek L. Connolly, Marcello Arca, Kausik K. Ray, Hermann Toplak, Per Hildebrandt, Ernst Rietzschel, Carlos Aguiar, Inaam Haq, David Nanchen, Jean Ferrières, Frank L.J. Visseren, Timo E. Strandberg, Ulrich Laufs, Aikaterini Bilitou, Jose M. Mostaza, Mats Eriksson, Alberico L. Catapano
Publikováno v: Atherosclerosis plus, vol. 43, pp. 24-30
Atherosclerosis Plus, Vol 43, Iss, Pp 24-30 (2021)
ATHEROSCLEROSIS PLUS
Background and aims: Clinical practice before 2019 suggests a substantial proportion of high and very high CV risk patients taking lipid-lowering therapy (LLT) would not achieve the new LDL-C goals recommended in the 2019 ESC/EAS guidelines (18 years
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4f2b6c52da9685431ffb8f04474bcb23
https://doi.org/10.1016/j.athplu.2021.08.003
Zobrazit plný text záznamu
7
Intravascular lithotripsy for severe coronary calcification: a systematic review
Autor: Azeem S Sheikh, Derek L Connolly, Chetan Varma, Fairoz Abdul, Vinoda Sharma
Publikováno v: Minerva cardiology and angiology.
Introduction Coronary artery calcification remains a challenge in percutaneous coronary interventions, due to the higher risk of suboptimal result with subsequent poor clinical outcomes. Intravascular lithotripsy is a novel way of treating severe cor
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dfea2ef6f2a010ef76ba5af099b107d9
https://pubmed.ncbi.nlm.nih.gov/34713678
Zobrazit plný text záznamu
8
GPVI inhibition by glenzocimab synergistically inhibits atherosclerotic plaque-induced platelet activation when combined with conventional dual antiplatelet therapy
Autor: Joshua Price, Steve P. Watson, Paulus Kirchhof, P Brady, M H Harbi, O Hargreaves, Pierre Mangin, Mark R Thomas, Alexandre Slater, Neena Kalia, Martine Jandrot-Perrus, Derek L. Connolly, Dean Kavanagh, Fawaz Obaidullah Alenazy, P H Harrison
Publikováno v: European Heart Journal. 42
Introduction Aspirin and a potent platelet P2Y12 inhibitor, such as prasugrel or ticagrelor, are not always sufficient to prevent thrombus formation in patients with ST-elevation MI (STEMI), leading to “slow flow” or “no reflow” effects after
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::6a05c62650eb0ce52c33d8dd5ddd3e28
https://doi.org/10.1093/eurheartj/ehab724.1425
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje